Obesity and Risk of Biochemical Failure for Patients Receiving Salvage Radiotherapy After Prostatectomy

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 4, 2009, Pages 1017-1022

  King, Christopher R ^a   Spiotto, Michael T ^a   Kapp, Daniel S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Body mass index; Prostate cancer; Salvage radiotherapy

Indexed keywords

DECISION MAKING; MULTIVARIANT ANALYSIS; RADIOTHERAPY; REGRESSION ANALYSIS;

BIOCHEMICAL FAILURES; BODY MASS INDEX; CATEGORICAL VARIABLES; FAILURE RATES; HAZARD RATIOS; MEDIAN TIME TO FAILURES; MULTI-VARIATE ANALYSIS; PROPORTIONAL HAZARDS; PROSTATE CANCER; PROSTATE-SPECIFIC ANTIGENS; RADICAL PROSTATECTOMIES; RISK FACTORS; SALVAGE RADIOTHERAPY; TECHNICAL DIFFICULTIES; UNIVARIATE;

NUTRITION;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RETROSPECTIVE STUDY; RISK FACTOR; SALVAGE THERAPY; TREATMENT FAILURE;

AGED; BODY MASS INDEX; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECURRENCE; REGRESSION ANALYSIS; RISK FACTORS; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 61349186999     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.05.041     Document Type: Article

References (26)

1. Calle E.E., Rodriguez C., Walker-Thurmond K., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348 (2003) 1625-1638
2. Renshaw A.G., Tyson M., Egger M., et al. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 371 (2008) 569-578
3. Freedland S.J., Terris M.K., Presti Jr. J.C., et al. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol 172 (2004) 520-524
4. Bassett W.W., Cooperberg M.R., Sadetsky N., et al. Impact of obesity on prostate cancer recurrence after radical prostatectomy: Data from CaPSURE. Urology 66 (2005) 1060-1065
5. Amling C.L., Riffenburgh R.H., Sun L., et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22 (2004) 439-445
6. Strom S.S., Wang X., Pettaway C.A., et al. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clin Cancer Res 11 (2005) 6889-6894
7. Loeb S., Yu X., Nadler R.B., et al. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?. J Urol 177 (2007) 102-106
8. Mallah K.N., DiBlasio C.J., Rhee A.C., et al. Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy. Cancer 103 (2005) 2030-2034
9. Freedland S.J., Isaacs W.B., Mangold L.A., et al. Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years. Clin Cancer Res 11 (2005) 2883-2888
10. Dahle S.E., Chokkalinggam A.P., Gao Y.T., et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 168 (2002) 599-604
11. Hammarsten J., and Hogstedt B. Hyperinsulinemia: A prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 41 (2005) 1887-1895
12. D'Amico A.V., Chen M.H., Roehl K.A., et al. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351 (2004) 125-135
13. Palma D., Pickles T., and Tyldesley S. Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer. BJU Int 100 (2007) 315-319
14. Strom S.S., Kamat A.M., Gruschkus S.K., et al. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 107 (2006) 631-639
15. Stroup S.P., Cullen J., Auge B.K., et al. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition. Cancer 110 (2007) 1003-1008
16. Efstathiou J.A., Chen M.-H., Renshaw A.A., et al. Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer. Cancer 109 (2007) 1493-1498
17. Merrick G.S., Butler W.M., Wallner K.E., et al. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy. Urology 65 (2005) 95-100
18. Merrick G.S., Galbreath R.W., Butler W.M., et al. Obesity is not predictive of overall survival following permanent prostate brachytherapy. Am J Clin Oncol 30 (2007) 588-596
19. Efstathiou J.A., Skowronski R.Y., Coen J.J., et al. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (2008) in press
20. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-The evidence report. Obes Res 6 Suppl. 2 (1998) 51S
21. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
22. Cox D.R. Regression models and life tables. J R Stat Soc Series B 34 (1972) 187-229
23. Vittinghoff E., and McCulloch C.E. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165 (2007) 710-718
24. King C.R., and Spiotto M.T. Improved outcomes with higher doses for patients receiving radiotherapy after prostatectomy. Int J Radiat Oncol Biol Phys 71 (2008) 23-27
25. King C.R., and Kapp D.S. Radiotherapy after prostatectomy: Is the evidence for dose escalation out there?. Int J Radiat Oncol Biol Phys 71 (2008) 346-350
26. Millender L.E., Aubin M., Pouliot J., et al. Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 59 (2004) 6-10